Lymphoma: all 5,624 studies
Page 40 of 57. Open to participants first (824), then studies with results posted, then the rest; newest registration first within each.
- 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell LymphomaStatus unknownNCT01678404Phase 2
- A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)Status unknownNCT01676558Phase 2
- Fluorodeoxyglucose Imaging Studies to Detect LymphomaWithdrawnNCT01672918
- Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of ElderlyWithdrawnNCT01671813Not applicable
- Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.Status unknownNCT01670370Phase 2
- Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell LymphomaStatus unknownNCT01667302Phase 2
- Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell LymphomaTerminatedNCT01667289Phase 2
- Personalized Therapy of Precursor Lymphoid NeoplasmsStatus unknownNCT01665001Phase 2
- Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph NodesCompletedNCT01664936
- Phase II Study of Age-Adjusted Rituximab, Bendamustine, Cytarabine as Induction Therapy in Older Patients With MCLCompletedNCT01662050Phase 2
- BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and HematologyCompletedNCT01660776
- Gemcitabine in NK/T Cell LymphomaCompletedNCT01660568
- GA In NEwly Diagnosed Diffuse Large B Cell LymphomaTerminatedNCT01659099Phase 3
- Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT01658319Phase 1
- Panobinostat Biological Correlates StudyCompletedNCT01658241Phase 2
- Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/LymphomaTerminatedNCT01658007Early Phase 1
- STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell LymphomaStatus unknownNCT01653067Phase 2
- Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)WithdrawnNCT01652261Phase 3
- A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell LymphomaCompletedNCT01652144Phase 2
- Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWithdrawnNCT01652014Phase 2
- A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)CompletedNCT01650727Phase 1
- Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)WithdrawnNCT01649622Phase 2
- Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaCompletedNCT01647971Phase 1/2
- Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis FungoidesStatus unknownNCT01645293Phase 1
- Phase 1b Safety and Efficacy Study of TRU-016TerminatedNCT01644253Phase 1
- Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesTerminatedNCT01643603Phase 1
- Lymphoma and T Helper 2 Cytokines Relationship With Prognostic MarkersCompletedNCT01639716
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
- Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins LymphomaTerminatedNCT01636388Phase 2
- Study of Safety and Preliminary Efficacy for LDK378 in Japanese Patients With Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)CompletedNCT01634763Phase 1
- Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell TransplantationCompletedNCT01634217Phase 1
- Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and OncologyCompletedNCT01626547
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasCompletedNCT01625351Phase 1
- Studying Genes Associated With Non-Hodgkin Lymphoma in Young PatientsCompletedNCT01623856
- Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell LymphomaCompletedNCT01622439Phase 1/2
- NK Cells in Cord Blood TransplantationStatus unknownNCT01619761Phase 1
- Osteonecroses in Pediatric Patients With ALLStatus unknownNCT01619124
- Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B PatientsCompletedNCT01613300Phase 2
- Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)CompletedNCT01611142Phase 2
- Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin LymphomaTerminatedNCT01609816Phase 1
- An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular LymphomaTerminatedNCT01609036
- Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant SurvivorsActive, not recruitingNCT01608152
- Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell LymphomaCompletedNCT01606605
- A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib TherapyCompletedNCT01599949Phase 2
- Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CTWithdrawnNCT01598558Not applicable
- Trial of Haploidentical Stem Cell Transplantation for Haematological CancersCompletedNCT01597219Phase 2
- A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT01594229Phase 1
- Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell LymphomaCompletedNCT01590732Phase 1
- A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or LymphomasCompletedNCT01588678Phase 1
- Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT01588015Phase 1
- Phase I/II Study of hLL1-DOX in Relapsed NHL and CLLTerminatedNCT01585688Phase 1/2
- Study of Lymphoma in AsiaCompletedNCT01584141
- Endomicroscopy and Gastric MALT-lymphomaCompletedNCT01583699Not applicable
- Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell LymphomaCompletedNCT01582776Phase 1/2
- Safety and Pharmacokinetic Profile of CKD-581CompletedNCT01580371Phase 1
- A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT01572519Phase 1
- Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin LymphomaStatus unknownNCT01570049Phase 3
- A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin LymphomaCompletedNCT01569750Phase 1
- Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell LymphomaCompletedNCT01569724Phase 4
- Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin LymphomaCompletedNCT01569204Phase 2
- Imetelstat for Children With Refractory or Recurrent Solid Tumors and LymphomaWithdrawnNCT01568632Phase 1
- Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaCompletedNCT01567709Phase 1
- The Combination of Rad001 and Rituximab In Patients With Non-hodgkin's LymphomasCompletedNCT01567475Phase 1
- Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters StudyCompletedNCT01565447
- A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or LymphomaCompletedNCT01564251Phase 1
- Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal ProteinsCompletedNCT01563874
- S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell LymphomaCompletedNCT01563861
- Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second RelapseCompletedNCT01562990Phase 1/2
- Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCLCompletedNCT01562977Phase 2
- PEARL Study: Improvement of Non-Hodgkin's Lymphoma CareStatus unknownNCT01562509Not applicable
- Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell LymphomaCompletedNCT01560117Phase 2
- Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
- Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid SequencingTerminatedNCT01556828
- Phase I/II Study of Abraxane in Recurrent and Refractory LymphomaTerminatedNCT01555853Phase 1
- A Study of Aneustat (OMN54) in Patients With Advanced Cancer and LymphomasCompletedNCT01555242Phase 1
- Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)CompletedNCT01553786Phase 2
- A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or LymphomaTerminatedNCT01551628Phase 1
- Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)Status unknownNCT01545544
- Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular LymphomaCompletedNCT01542918Phase 1
- Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell TransplantationTerminatedNCT01541072Not applicable
- Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell LymphomaWithdrawnNCT01539174Phase 2
- Phase II Evaluation of Gemcitabine- Rituximab-Oxaliplatin Combination (GROC) in Relapsed Aggressive LymphomasCompletedNCT01538641Phase 2
- Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphomaCompletedNCT01535989Phase 1
- Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence TrialTerminatedNCT01534949Phase 1
- IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic LeukemiaCompletedNCT01534715Phase 1
- Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in LymphomaWithdrawnNCT01528865Phase 1/2
- Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHLCompletedNCT01527422Phase 1/2
- A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc IntervalCompletedNCT01525394Phase 1
- Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular LymphomaCompletedNCT01523860Phase 2
- A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL)CompletedNCT01523847Phase 2
- Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid MalignanciesCompletedNCT01523223Phase 1
- Brown Fat Activity and White Fat AccumulationCompletedNCT01517581
- Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced ThrombocytopeniaCompletedNCT01516619Phase 2
- Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone LymphomaCompletedNCT01516606Phase 2
- Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt LymphomaCompletedNCT01516593Phase 2
- Intralesional Rituximab for the Treatment of Conjunctival Indolent LymphomaCompletedNCT01514344Phase 2
- Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic LeukemiaStatus unknownNCT01513603Phase 2
- Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical TrialCompletedNCT01505712
- Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)CompletedNCT01504776Phase 1
- Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)CompletedNCT01502982Phase 2